Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)
China · Delayed Price · Currency is CNY 18.93
-0.44 (-2.27%)
Nov 13, 2026, 3:04 PM CST
SHE:300813 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 163.19 | 149.09 | 264.87 | 396.98 | 577.15 | 302.46 |
Short-Term Investments | - | 122.39 | 134.97 | - | - | - |
Trading Asset Securities | 45.15 | 61.12 | - | - | - | 20.05 |
Cash & Short-Term Investments | 208.35 | 332.6 | 399.84 | 396.98 | 577.15 | 322.51 |
Cash Growth | 52.00% | -16.82% | 0.72% | -31.22% | 78.96% | 0.11% |
Accounts Receivable | 70.21 | 72.82 | 62.39 | 46.98 | 60.71 | 54.07 |
Other Receivables | 7.08 | 7.4 | 8.49 | 8.95 | 3.38 | 3.63 |
Receivables | 77.29 | 80.22 | 70.88 | 55.92 | 64.09 | 57.7 |
Inventory | 144.38 | 126.54 | 144.13 | 160.55 | 111.2 | 122.45 |
Other Current Assets | 115.95 | 10.49 | 17.91 | 25.29 | 11.1 | 11.8 |
Total Current Assets | 545.97 | 549.85 | 632.76 | 638.75 | 763.54 | 514.46 |
Property, Plant & Equipment | 287.11 | 260.05 | 266.71 | 269.06 | 118.51 | 106.04 |
Long-Term Investments | 66.77 | 66 | 8.14 | 4 | - | - |
Other Intangible Assets | 26.69 | 27.39 | 10.92 | 11.27 | 11.82 | 12.37 |
Long-Term Deferred Tax Assets | 0.16 | 0.17 | 0.09 | 0.92 | 3.77 | 0.82 |
Long-Term Deferred Charges | 27.07 | 29.07 | 31.25 | 31.85 | 12.97 | 8.46 |
Other Long-Term Assets | 8.48 | 26.44 | 10.04 | 17.66 | 12.05 | 13.73 |
Total Assets | 962.24 | 958.97 | 959.91 | 973.51 | 922.66 | 655.87 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 20.05 | 15.86 | 15.19 | 14.76 | 14.28 | 16.67 |
Accrued Expenses | 21 | 32.56 | 30.33 | 32.9 | 31.98 | 29.56 |
Short-Term Debt | - | - | 3.67 | - | - | - |
Current Portion of Leases | - | - | - | - | - | 3.47 |
Current Income Taxes Payable | 3.76 | - | - | - | 0.11 | 0.96 |
Current Unearned Revenue | 92.61 | 65.73 | 76.58 | 94.45 | 72.03 | 91.56 |
Other Current Liabilities | 16.36 | 37.99 | 10.01 | 19.71 | 10.93 | 11.24 |
Total Current Liabilities | 153.78 | 152.14 | 135.79 | 161.81 | 129.33 | 153.46 |
Long-Term Debt | - | - | - | 157.59 | 145.47 | - |
Long-Term Leases | - | - | - | - | - | 3.74 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.06 |
Long-Term Deferred Tax Liabilities | 2.25 | 2.55 | 3.39 | 3.87 | 0.41 | 1.23 |
Total Liabilities | 156.03 | 154.68 | 139.18 | 323.27 | 275.21 | 158.49 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 121.2 | 121.2 | 121.2 | 108.71 | 83.17 | 51.97 |
Additional Paid-In Capital | 401.94 | 412.5 | 420.51 | 194.16 | 212.77 | 228.02 |
Retained Earnings | 283.07 | 270.59 | 278.34 | 276.21 | 281.49 | 217.39 |
Comprehensive Income & Other | - | - | - | 69.69 | 70.03 | - |
Total Common Equity | 806.21 | 804.29 | 820.05 | 648.76 | 647.45 | 497.38 |
Minority Interest | - | - | 0.68 | 1.48 | - | - |
Shareholders' Equity | 806.21 | 804.29 | 820.73 | 650.24 | 647.45 | 497.38 |
Total Liabilities & Equity | 962.24 | 958.97 | 959.91 | 973.51 | 922.66 | 655.87 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | - | - | 3.67 | 157.59 | 145.47 | 7.21 |
Net Cash (Debt) | 208.35 | 332.6 | 396.17 | 239.39 | 431.69 | 315.3 |
Net Cash Growth | 52.00% | -16.05% | 65.49% | -44.55% | 36.91% | -2.13% |
Net Cash Per Share | 1.78 | 2.82 | 3.64 | 2.07 | 3.85 | 2.90 |
Filing Date Shares Outstanding | 126.54 | 121.2 | 119.99 | 108.71 | 108.12 | 108.1 |
Total Common Shares Outstanding | 126.54 | 121.2 | 121.2 | 108.71 | 108.12 | 108.1 |
Working Capital | 392.18 | 397.71 | 496.98 | 476.94 | 634.21 | 360.99 |
Book Value Per Share | 6.37 | 6.64 | 6.77 | 5.97 | 5.99 | 4.60 |
Tangible Book Value | 779.52 | 776.9 | 809.13 | 637.49 | 635.64 | 485.01 |
Tangible Book Value Per Share | 6.16 | 6.41 | 6.68 | 5.86 | 5.88 | 4.49 |
Buildings | - | 232.64 | 232.59 | 229.38 | 77.26 | 76.39 |
Machinery | - | 94.37 | 88.44 | 80.31 | 60.96 | 47.65 |
Construction In Progress | - | 9.26 | 6.66 | 4.27 | 15.93 | 0.66 |